Posted by:
Sandi Krul,
Karl Schmitz &
Kerry Sakimoto
On August 5, 2024, California’s Office of Health Care Affordability (“OHCA”) published its proposed revisions to the Cost and Market Impact Review (“CMIR”) regulations (22 Cal. Code Regs. §§ 97431 et seq.). This published version includes revisions to OHCA’s May 15, 2024 prior draft, which were the subject of CSHA’s June 25, 2024 edition of Watching and discussed at the California Department of Health Care Access and Information’s Health Care Affordability Board’s June board meeting (see also the meeting minutes from the June board meeting). OHCA received a total of six (6) public comments on the prior draft.
One of the most substantive proposed changes is to expand the pool of potential submitters to OHCA from health care entities that are a “party to” a material change transaction, to now also include health care entities that are “a subject of” a material change transaction, even if that health care entity is not a party to the transaction. The prior draft of the proposed revisions defined being “a subject of” a transaction to mean that the transaction “concerns a health care entity’s assets, control, responsibility, governance or operations, in whole or in part.” (emphasis added). However, the revised version defines being a “subject of” a transaction to mean that the transaction “will result in the transfer, as used in [22 Cal. Code Regs. § 97431(p)], of a health care entity’s assets, control, responsibility, governance, or operations, in whole or in part to one or more entities.” (emphasis added).
This narrowed definition was in response to public comments that OHCA’s prior proposed definition using the term “concerns” was unclear and overly broad, and that capturing all transactions that “concern” a health care entity’s assets, control, responsibility, governance or operations would arguably reach beyond OHCA’s statutory authority. Despite OHCA’s revisions to narrow the definition of a health care entity that is a “subject of” a material change transaction, the proposed revised regulations, if the Office of Administrative Law (the “OAL”) approves and files them with the Secretary of State, would still mean that transactions that previously would have not have required a filing with OHCA may now be subject to OHCA’s review.
For example, in OHCA’s Findings of Emergency Regulations and Notice of Proposed Emergency Regulations, published on August 5, 2024 (“Findings”), OHCA describes its rationale for expanding the regulations to include health care entities that are a “subject of” a material change transaction. OHCA explains that this proposed change is in response to questions regarding whether a notice is required for transactions in which non-health care entities (e.g., holding companies or parent owners of a health care entity) transfer assets or control of a subsidiary health care entity, even though the subsidiary health care entity itself is not a party to the transaction. Accordingly, if the revised regulations are finalized in its current form, such transactions may now be subject to OHCA’s review, as the subsidiary health care entity would ostensibly be a “subject of” the parent entity’s transaction. Therefore, under the revised regulations, the subsidiary health care entity may be required to file notice with OHCA, even if the subsidiary health care entity is not itself a party to such transaction.
OHCA further comments in its Findings that the proposed revised regulations are intended to align with OHCA’s statutory authority to review notices from health care entities for transactions that either (1) sell, transfer, lease, exchange, option, encumber, convey, or otherwise dispose of a material amount of its assets to one or more entities, or (2) that transfer control, responsibility, or governance of a material amount of the assets or operations of a health care entity to one or more entities, regardless of the health care entity’s role in the transaction.
Pursuant to OHCA’s Notification of Proposed Emergency Regulatory Action, OHCA filed the revised regulations with the OAL on August 13, 2024. The OAL has until August 23, 2024 to review and either approve or disapprove the revised regulations. The public has until August 19, 2024 to submit additional public comments.